Can You Get Ascites from Fatty Liver?

Fatty liver disease can cause ascites, but only once it has advanced to cirrhosis. Many people diagnosed with fatty liver, now termed metabolic dysfunction-associated steatotic liver disease (MASLD) in UK practice, worry about this serious complication. Understanding how fatty liver progresses, what warning signs to watch for, and how the NHS diagnoses and manages ascites can help you take timely action. Crucially, early-stage fatty liver is reversible, and lifestyle changes made before cirrhosis develops can prevent ascites from ever occurring.

Can fatty liver disease really cause ascites?

Fatty liver disease causes ascites only when it has progressed to cirrhosis, where portal hypertension and reduced albumin production allow fluid to accumulate in the abdominal cavity.

Yes, fatty liver disease can cause ascites, but only when it has progressed to an advanced stage known as cirrhosis. Fatty liver disease, medically termed hepatic steatosis, exists on a spectrum. In its early form, fat accumulates in liver cells without causing significant inflammation or scarring. This stage is generally reversible and does not directly cause ascites.

UK hepatology services now use the term metabolic dysfunction-associated steatotic liver disease (MASLD), which replaces the older term non-alcoholic fatty liver disease (NAFLD).^[1][2] You may encounter both terms in NHS letters and patient information. When MASLD progresses to cause inflammation, it is called metabolic dysfunction-associated steatohepatitis (MASH, previously NASH).^[1][2] Persistent inflammation can lead to fibrosis and, ultimately, cirrhosis.

Cirrhosis is the point at which ascites becomes a genuine risk. Extensive scarring disrupts normal liver architecture, raising pressure within the portal vein (portal hypertension). This elevated pressure, combined with reduced production of albumin by the damaged liver, causes fluid to leak from blood vessels into the abdominal cavity, producing ascites. Not everyone with fatty liver will reach this stage. Many people with simple fatty liver, particularly those who make meaningful lifestyle changes early, never develop cirrhosis.

The progression from fatty liver to cirrhosis typically takes many years and is influenced by factors including obesity, type 2 diabetes, alcohol use, and genetic predisposition. In primary care, a blood test called FIB-4 (Fibrosis-4 index) is used as a first-line tool to assess the risk of significant fibrosis.^[5][4] People with an intermediate or high FIB-4 score may be referred for further testing, such as an enhanced liver fibrosis (ELF) test, and onward referral to a hepatologist where appropriate.^[4][5] NICE guidance (NG49) sets out these risk stratification and referral pathways. Regular monitoring by a GP or liver specialist is important for anyone diagnosed with fatty liver disease, particularly if additional risk factors are present.

What are the signs that ascites has developed?

The main sign of ascites is a gradually distended, tight abdomen, often accompanied by breathlessness, ankle swelling, reduced appetite, and fatigue reflecting underlying liver dysfunction.

The most recognisable sign of ascites is a visibly swollen or distended abdomen, which may feel tight or uncomfortable and can develop gradually over weeks. In the early stages, the fluid accumulation may be subtle and only detectable on clinical examination or imaging. As the volume of fluid increases, the abdomen becomes noticeably enlarged, and patients may notice that their waistbands no longer fit or that their weight has increased despite no change in diet.

Other symptoms that commonly accompany ascites include:

• Shortness of breath, particularly when lying flat, as the fluid pushes upward against the diaphragm

• Reduced appetite and early satiety, caused by pressure on the stomach

• Ankle and leg swelling (peripheral oedema), which often occurs alongside abdominal fluid

• Fatigue and general malaise, reflecting underlying liver dysfunction

• Nausea or a sensation of bloating

Some symptoms may indicate serious complications of cirrhosis and require urgent medical attention. Call 999 or go to the nearest accident and emergency department immediately if you or someone else experiences:

• Fever, worsening abdominal pain, or sudden deterioration in general health, which may indicate spontaneous bacterial peritonitis (SBP), a life-threatening infection of the ascitic fluid

• Confusion, drowsiness, or difficulty thinking clearly, which may suggest hepatic encephalopathy

• Vomiting blood, or passing black or tarry stools, which may indicate bleeding from oesophageal or gastric varices

• New or rapidly worsening jaundice (yellowing of the skin or whites of the eyes)

For symptoms that are new or worsening but not immediately life-threatening, such as increasing abdominal swelling or breathlessness, contact your GP promptly or call NHS 111 for guidance on the appropriate next step.

How is ascites diagnosed and treated on the NHS?

Ascites is confirmed by ultrasound and diagnostic ascitic tap; NHS treatment includes dietary sodium restriction, diuretics, large-volume paracentesis with albumin infusion, and hepatology follow-up.

Ascites is diagnosed through a combination of clinical examination, blood tests, and imaging, with ultrasound being the standard first-line investigation recommended by NICE (NG50) and widely available on the NHS.^[6][7] A doctor will typically assess for shifting dullness and fluid thrill on abdominal examination, then confirm the diagnosis with an ultrasound scan. Blood tests including liver function tests, albumin, clotting studies, and a full blood count help to assess the severity of underlying liver disease.

UK guidance (BSG/BASL) recommends that all patients with new-onset ascites, and those admitted to hospital with ascites, should have a prompt diagnostic ascitic tap (paracentesis) to exclude spontaneous bacterial peritonitis (SBP), regardless of whether the cause of ascites is already known. A small sample of fluid is withdrawn using a needle and sent for analysis, including cell count, albumin, and culture. The serum-ascites albumin gradient (SAAG) helps distinguish portal hypertension-related ascites from other causes.^[7]

Treatment on the NHS is guided by the severity of ascites and the underlying condition:

• Dietary sodium restriction is a cornerstone of management, to reduce fluid retention. UK guidance recommends a low-salt diet; your clinical team will advise on the specific target appropriate for you

• Diuretic therapy, most commonly spironolactone with or without furosemide, is used to promote fluid excretion.^[7][8] Monitoring of renal function, electrolytes, and daily weight is essential during diuretic treatment, and your clinical team will arrange this. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen should be avoided, as they can worsen kidney function and fluid retention in people with cirrhosis^[10]

• Fluid restriction is not routinely recommended for ascites management but may be advised by your clinical team if you develop significant low sodium levels (hyponatraemia)

• Large-volume paracentesis is performed for tense or refractory ascites, where large volumes of fluid are drained under clinical supervision. Intravenous albumin infusion is recommended alongside drainage of large volumes to reduce the risk of circulatory complications

• Antibiotic prophylaxis may be recommended for selected patients at high risk of SBP, or following a first episode, in line with UK guidance

• Transjugular intrahepatic portosystemic shunt (TIPS) may be considered in selected patients with refractory ascites to reduce portal pressure

• Liver transplantation remains the only definitive treatment for end-stage liver disease causing ascites, and referral to a specialist centre is made where appropriate

Regular follow-up with a hepatologist is essential to monitor response to treatment and adjust management. Referral to hepatology is recommended for anyone with refractory ascites, recurrent SBP, deteriorating kidney function, or suspected advanced disease.

Can you reverse fatty liver before ascites develops?

Early fatty liver and mild fibrosis can be reversed with sustained lifestyle changes, including 7 to 10 per cent body weight reduction, dietary improvement, exercise, and alcohol reduction.

Fatty liver disease in its early stages is reversible, and addressing it before cirrhosis develops is the most effective way to prevent ascites from occurring. Simple hepatic steatosis and even early fibrosis can improve significantly with sustained lifestyle changes. The liver has a remarkable capacity for regeneration when the underlying cause of damage is removed or reduced.

The most evidence-based interventions for reversing fatty liver include:

• Weight loss: Clinical studies show that a reduction of 7 to 10 per cent of body weight can reduce liver fat, inflammation, and fibrosis in people with MASH (NICE NG49)^[4][9]

• Dietary change: A diet low in ultra-processed foods, refined carbohydrates, and added sugars, and rich in vegetables, wholegrains, and unsaturated fats, supports liver health

• Physical activity: Both aerobic exercise and resistance training independently reduce liver fat, even without significant weight loss

• Alcohol reduction or abstinence: Alcohol accelerates liver damage in people with fatty liver disease and should be minimised

• Management of metabolic conditions: Optimising blood glucose control in type 2 diabetes, treating hypertension, and managing dyslipidaemia all reduce the rate of liver disease progression

For people who are struggling to achieve sufficient weight loss through lifestyle changes alone, a GP may discuss whether pharmacological support is appropriate. It is important to note that no medicines are currently licensed in the UK specifically to treat MASLD or MASH.^[13] However, certain medicines used for weight management or type 2 diabetes have shown benefits for liver health in clinical trials, and a prescriber can advise on suitability for individual patients. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be explored.

In primary care, FIB-4 testing can help identify people with fatty liver who are at higher risk of progression, so that monitoring and referral can be arranged promptly. If fatty liver has already progressed to advanced fibrosis or cirrhosis, reversal becomes more difficult, though halting further progression remains a realistic and important goal. Anyone with a diagnosis of fatty liver disease should discuss their individual risk and monitoring plan with their GP.

Scientific References

1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
2. Understanding the evolving nomenclature of steatotic liver disease.
3. Metabolic dysfunction-associated steatotic liver disease (MASLD): draft scope post-referral.
4. Metabolic dysfunction-associated steatotic liver disease (NAFLD): diagnosis and management. NG49.
5. LIVERFASt for assessing and monitoring liver fibrosis, activity and steatosis. MIB317.
6. Cirrhosis in over 16s: assessment and management. NG50.
7. Cirrhosis in over 16s: assessment and management. NG50 — recommendations chapter.
8. Cirrhosis.
9. Non-alcoholic fatty liver disease (NAFLD).
10. Prescribing in hepatic impairment.
11. Albumin infusion in patients undergoing large-volume paracentesis.
12. TIPS — research recommendation. NG50.
13. Semaglutide (Wegovy) approved to treat form of liver disease.

Frequently Asked Questions